Literature DB >> 19020897

Increased nitric oxide production by neutrophils in early stage of Kawasaki disease.

Ken Yoshimura1, Kimiko Tatsumi, Anna Iharada, Shoji Tsuji, Ai Tateiwa, Masayuki Teraguchi, Hirotaro Ogino, Kazunari Kaneko.   

Abstract

Recent observations suggested that nitric oxide (NO) has a role in triggering the early endothelial dysfunction in Kawasaki disease (KD). We investigated the amount of NO in conjunction with reactive oxygen species (ROS) produced by neutrophils in children with acute KD by a newly developed flow cytometric analysis. Forty children with acute KD (n = 14), non-KD febrile disease (n = 14), and afebrile control (n = 12) were enrolled (age, 3 to 88 months). Neutrophils in KD produced significantly higher amount of NO compared to others (p < 0.05). With regard to ROS, significant increase was not only found in KD but also in non-KD febrile children (p < 0.05 and p < 0.01, respectively). In KD patients, the amount of NO produced by neutrophils decreased after immunoglobulin (IVIG) treatment, while there was no significant change in ROS production. The amount of NO in KD patients also correlated well with the days from the onset. One patient who developed coronary arterial lesion showed the highest value of NO. In conclusion, neutrophils in acute KD generate both NO and ROS considerably, while NO production is exclusive in the early stage of KD before IVIG treatment. Abnormal immune system in KD might be characterized by an overproduction of NO, whereas the role of NO in endothelial damage remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19020897     DOI: 10.1007/s00431-008-0872-1

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  22 in total

Review 1.  Antimicrobial reactive oxygen and nitrogen species: concepts and controversies.

Authors:  Ferric C Fang
Journal:  Nat Rev Microbiol       Date:  2004-10       Impact factor: 60.633

2.  The riddle of Kawasaki disease.

Authors:  Jane C Burns
Journal:  N Engl J Med       Date:  2007-02-15       Impact factor: 91.245

Review 3.  Nitric oxide synthases: roles, tolls, and controls.

Authors:  C Nathan; Q W Xie
Journal:  Cell       Date:  1994-09-23       Impact factor: 41.582

Review 4.  Inducible nitric oxide synthase in human diseases.

Authors:  K D Kröncke; K Fehsel; V Kolb-Bachofen
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

5.  Development of novel fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species.

Authors:  Ken-ichi Setsukinai; Yasuteru Urano; Katsuko Kakinuma; Hideyuki J Majima; Tetsuo Nagano
Journal:  J Biol Chem       Date:  2002-11-04       Impact factor: 5.157

6.  Dramatic decrease of circulating levels of monocyte chemoattractant protein-1 in Kawasaki disease after gamma globulin treatment.

Authors:  M Terai; T Jibiki; A Harada; Y Terashima; K Yasukawa; S Tateno; H Hamada; S Oana; H Niimi; K Matsushima
Journal:  J Leukoc Biol       Date:  1999-05       Impact factor: 4.962

7.  Inflammatory gene polymorphisms and susceptibility to kawasaki disease and its arterial sequelae.

Authors:  Yiu-Fai Cheung; Guo-Ying Huang; Shu-Bao Chen; Xiao-Qin Liu; Li Xi; Xue-Cun Liang; Mei-Rong Huang; Sun Chen; Li-Su Huang; Xiao-Qing Liu; Koon-Wing Chan; Yu-Lung Lau
Journal:  Pediatrics       Date:  2008-08-18       Impact factor: 7.124

8.  Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins.

Authors:  H Kojima; N Nakatsubo; K Kikuchi; S Kawahara; Y Kirino; H Nagoshi; Y Hirata; T Nagano
Journal:  Anal Chem       Date:  1998-07-01       Impact factor: 6.986

Review 9.  Nitric oxide: mediator, murderer, and medicine.

Authors:  E Anggård
Journal:  Lancet       Date:  1994-05-14       Impact factor: 79.321

10.  ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms.

Authors:  Yoshihiro Onouchi; Tomohiko Gunji; Jane C Burns; Chisato Shimizu; Jane W Newburger; Mayumi Yashiro; Yoshikazu Nakamura; Hiroshi Yanagawa; Keiko Wakui; Yoshimitsu Fukushima; Fumio Kishi; Kunihiro Hamamoto; Masaru Terai; Yoshitake Sato; Kazunobu Ouchi; Tsutomu Saji; Akiyoshi Nariai; Yoichi Kaburagi; Tetsushi Yoshikawa; Kyoko Suzuki; Takeo Tanaka; Toshiro Nagai; Hideo Cho; Akihiro Fujino; Akihiro Sekine; Reiichiro Nakamichi; Tatsuhiko Tsunoda; Tomisaku Kawasaki; Yusuke Nakamura; Akira Hata
Journal:  Nat Genet       Date:  2007-12-16       Impact factor: 38.330

View more
  13 in total

1.  Inter- and intra-subject variability of nitric oxide levels in leukocyte subpopulations.

Authors:  Sheena Maharaj; Kim D Lu; Shlomit Radom-Aizik; Frank Zaldivar; Fadia Haddad; Hye-Won Shin; Szu-Yun Leu; Eliezer Nussbaum; Inderpal Randhawa; Dan M Cooper
Journal:  Nitric Oxide       Date:  2017-11-09       Impact factor: 4.427

2.  Intravenous immunoglobulin counteracts oxidative stress in Kawasaki disease.

Authors:  Kazunari Kaneko; Masaya Takahashi; Ken Yoshimura; Tetsuya Kitao; Sohsaku Yamanouchi; Takahisa Kimata; Shoji Tsuji
Journal:  Pediatr Cardiol       Date:  2012-02-11       Impact factor: 1.655

3.  Nitric oxide-mediated coronary flow regulation in patients with coronary artery disease: recent advances.

Authors:  Noboru Toda; Shinichi Tanabe; Sadanobu Nakanishi
Journal:  Int J Angiol       Date:  2011-09

4.  DC-SIGN (CD209) promoter -336 A/G (rs4804803) polymorphism associated with susceptibility of Kawasaki disease.

Authors:  Hong-Ren Yu; Wei-Pin Chang; Lin Wang; Ying-Jui Lin; Chi-Di Liang; Kuender D Yang; Chiu-Ming Kuo; Yi-Chuan Huang; Wei-Chiao Chang; Ho-Chang Kuo
Journal:  ScientificWorldJournal       Date:  2012-05-02

5.  GM-CSF primes cardiac inflammation in a mouse model of Kawasaki disease.

Authors:  Angus T Stock; Jacinta A Hansen; Matthew A Sleeman; Brent S McKenzie; Ian P Wicks
Journal:  J Exp Med       Date:  2016-09-05       Impact factor: 14.307

6.  Unique Molecular Patterns Uncovered in Kawasaki Disease Patients with Elevated Serum Gamma Glutamyl Transferase Levels: Implications for Intravenous Immunoglobulin Responsiveness.

Authors:  Yue Wang; Zhen Li; Guang Hu; Shiying Hao; Xiaohong Deng; Min Huang; Miao Ren; Xiyuan Jiang; John T Kanegaye; Kee-Soo Ha; JungHwa Lee; Xiaofeng Li; Xuejun Jiang; Yunxian Yu; Adriana H Tremoulet; Jane C Burns; John C Whitin; Andrew Y Shin; Karl G Sylvester; Doff B McElhinney; Harvey J Cohen; Xuefeng B Ling
Journal:  PLoS One       Date:  2016-12-21       Impact factor: 3.240

7.  Anti-inflammatory effect of resveratrol in human coronary arterial endothelial cells via induction of autophagy: implication for the treatment of Kawasaki disease.

Authors:  Fu-Chen Huang; Ho-Chang Kuo; Ying-Hsien Huang; Hong-Ren Yu; Sung-Chou Li; Hsing-Chun Kuo
Journal:  BMC Pharmacol Toxicol       Date:  2017-01-09       Impact factor: 2.483

8.  Significance of Differential Characteristics in Infantile Kawasaki Disease.

Authors:  Ji Hee Kwak; JungHwa Lee; Kee Soo Ha
Journal:  Korean Circ J       Date:  2019-04-05       Impact factor: 3.243

Review 9.  Kawasaki disease: aetiopathogenesis and therapeutic utility of intravenous immunoglobulin.

Authors:  Caroline Galeotti; Jagedeesh Bayry; Isabelle Kone-Paut; Srinivas V Kaveri
Journal:  Autoimmun Rev       Date:  2010-01-13       Impact factor: 9.754

Review 10.  Predisposing factors, pathogenesis and therapeutic intervention of Kawasaki disease.

Authors:  Caroline Galeotti; Srini V Kaveri; Rolando Cimaz; Isabelle Koné-Paut; Jagadeesh Bayry
Journal:  Drug Discov Today       Date:  2016-08-06       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.